Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1981 1
1982 1
1984 2
1985 7
1986 8
1987 13
1988 15
1989 10
1990 21
1991 21
1992 23
1993 27
1994 32
1995 38
1996 47
1997 70
1998 71
1999 98
2000 144
2001 172
2002 177
2003 229
2004 328
2005 337
2006 413
2007 507
2008 769
2009 937
2010 1145
2011 1212
2012 1516
2013 1665
2014 1839
2015 1979
2016 2028
2017 2315
2018 2650
2019 2912
2020 3739
2021 4463
2022 4819
2023 4648
2024 1539

Text availability

Article attribute

Article type

Publication date

Search Results

39,064 results

Results by year

Filters applied: Abstract, Free full text. Clear all
Page 1
Drug treatments in Alzheimer's disease.
Briggs R, Kennelly SP, O'Neill D. Briggs R, et al. Clin Med (Lond). 2016 Jun;16(3):247-53. doi: 10.7861/clinmedicine.16-3-247. Clin Med (Lond). 2016. PMID: 27251914 Free PMC article. Review.
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD) and these act to control symptoms rather than alter the course of the disease. ...However, we currently remai …
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's …
Alzheimer's disease.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Scheltens P, et al. Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2. Lancet. 2021. PMID: 33667416 Free PMC article. Review.
The risk of Alzheimer's disease is 60-80% dependent on heritable factors, with more than 40 Alzheimer's disease-associated genetic risk loci already identified, of which the APOE alleles have the strongest association with the disease …
The risk of Alzheimer's disease is 60-80% dependent on heritable factors, with more than 40 Alzheimer's …
Alzheimer's disease.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Ballard C, et al. Lancet. 2011 Mar 19;377(9770):1019-31. doi: 10.1016/S0140-6736(10)61349-9. Epub 2011 Mar 1. Lancet. 2011. PMID: 21371747 Free article. Review.
An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease. Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority. Altho …
An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease. T …
Neuropsychiatric symptoms in Alzheimer's disease.
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Lyketsos CG, et al. Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410. Alzheimers Dement. 2011. PMID: 21889116 Free PMC article.
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms are currently known to manifest commonly in very early disease and …
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge …
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease.
Khan S, Barve KH, Kumar MS. Khan S, et al. Curr Neuropharmacol. 2020;18(11):1106-1125. doi: 10.2174/1570159X18666200528142429. Curr Neuropharmacol. 2020. PMID: 32484110 Free PMC article. Review.
BACKGROUND: The only conclusive way to diagnose Alzheimer's is to carry out brain autopsy of the patient's brain tissue and ascertain whether the subject had Alzheimer's or any other form of dementia. ...Thus, a standard drug regimen ensues in every …
BACKGROUND: The only conclusive way to diagnose Alzheimer's is to carry out brain autopsy of the patient's brain tissue and as …
The essential elements of Alzheimer's disease.
Lei P, Ayton S, Bush AI. Lei P, et al. J Biol Chem. 2021 Jan-Jun;296:100105. doi: 10.1074/jbc.REV120.008207. Epub 2020 Nov 27. J Biol Chem. 2021. PMID: 33219130 Free PMC article. Review.
Treatments for Alzheimer's disease (AD) directed against the prominent amyloid plaque neuropathology are yet to be proved effective despite many phase 3 clinical trials. ...Here, we review these essential elements of AD for their broad potential to con …
Treatments for Alzheimer's disease (AD) directed against the prominent amyloid plaque neuropathology are yet to …
Present Algorithms and Future Treatments for Alzheimer's Disease.
Grossberg GT, Tong G, Burke AD, Tariot PN. Grossberg GT, et al. J Alzheimers Dis. 2019;67(4):1157-1171. doi: 10.3233/JAD-180903. J Alzheimers Dis. 2019. PMID: 30741683 Free PMC article. Review.
An estimated 47 million people live with Alzheimer's disease (AD) and other forms of dementia worldwide. Although no disease-modifying treatments are currently available for AD, earlier diagnosis and proper management of the disease could …
An estimated 47 million people live with Alzheimer's disease (AD) and other forms of dementia worldwide. Although no …
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E. Passeri E, et al. Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954. Int J Mol Sci. 2022. PMID: 36430432 Free PMC article. Review.
Alzheimer's disease (AD) is the most frequent case of neurodegenerative disease and is becoming a major public health problem all over the world. ...The prevention methods can significantly slow AD evolution and are currently the best strategy possible …
Alzheimer's disease (AD) is the most frequent case of neurodegenerative disease and is becoming a major public h …
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.
Cummings JL, Tong G, Ballard C. Cummings JL, et al. J Alzheimers Dis. 2019;67(3):779-794. doi: 10.3233/JAD-180766. J Alzheimers Dis. 2019. PMID: 30689575 Free PMC article. Review.
Although Alzheimer's disease (AD) is the world's leading cause of dementia and the population of patients with AD continues to grow, no new therapies have been approved in more than a decade. ...The goal of this narrative literature review is to describe type …
Although Alzheimer's disease (AD) is the world's leading cause of dementia and the population of patients with AD conti …
Current understanding of Alzheimer's disease diagnosis and treatment.
Weller J, Budson A. Weller J, et al. F1000Res. 2018 Jul 31;7:F1000 Faculty Rev-1161. doi: 10.12688/f1000research.14506.1. eCollection 2018. F1000Res. 2018. PMID: 30135715 Free PMC article. Review.
Alzheimer's disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. ...Here, we discuss recent advances in our understanding of the clinical evaluation and treatment …
Alzheimer's disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part beca …
39,064 results
You have reached the last available page of results. Please see the User Guide for more information.